Efavirenz/emtricitabine/tenofovir disoproxil vs Oseltamivir phosphate
Oseltamivir phosphate was dispensed 867.0× as often as Efavirenz/emtricitabine/tenofovir disoproxil in September 2025 — 867 items versus 1 in England.
1items
Efavirenz/emtricitabine/tenofovir disoproxil · September 2025
NHSBSA Prescription Cost Analysis
867items
Oseltamivir phosphate · September 2025
NHSBSA Prescription Cost Analysis
Figure 1. Efavirenz/emtricitabine/tenofovir disoproxil versus Oseltamivir phosphate: national items dispensed by month
▬ Efavirenz/emtricitabine/tenofovir disoproxil · ╌ Oseltamivir phosphate
Source: NHSBSA Prescription Cost Analysis, to September 2025
| Measure | Efavirenz/emtricitabine/tenofovir disoproxil | Oseltamivir phosphate |
|---|---|---|
| Items, September 2025 | 1 | 867 |
| Items, last 12 months | 12 | 38,013 |
| Net ingredient cost, September 2025 | £533 | £13,394 |
See the full profile for Efavirenz/emtricitabine/tenofovir disoproxil or Oseltamivir phosphate.